pricing
Many people will tell you that their health is everything!
That is, unless they have to pay anything for it.
Currently the price for a 2 cc infusion is $6,900.
My company, Stem Cell Therapy, Inc, is working with the doctor/owners of WBRx to establish volume pricing to give participants an incentive to establish a Long-term program with SCT-INC & WBRx. Please use the "CONTACT US" page to describe your situation (age, health issues) and we can customize a long-term program to suit your needs.
$6,900 is too much! Really, consider this:
The first commercially available cell phone was the Motorola DynaTAC 8000X, introduced in 1983. It cost approximately $3,995 at the time, which is equivalent to about $16,000 today, adjusted for inflation. The phone had a talk time of about 30 minutes per battery charge and required about 10 hours to fully recharge. Despite its limitations, it marked the beginning of the mobile phone revolution. And now almost everybody has one! Just think if everybody decided that the cell phone was too expensive and everybody refused to buy one, then nobody would have one today. And we would still have an abundance of phone booths. When is the last time you saw a phone booth?
If a person cannot afford or doesn't want to afford the therapy, it is entirely understandable. The only reason to understand this therapy is that things change in the medical field very rapidly with regard to outside funding, FDA approval (which would mean that this therapy would be paid by insurance), etc. The more people understand the benefits of this therapy - and understand that the short-term cost will far outweigh the long term cost and tremendous health benefits that stem cell therapy can provide, the sooner that this therapy can become mainstream. So, "stay tuned"!
The reality is that health care is just plain expensive!
Last year my out-of-pocket cost was just under $100,000. Revlimid, a prescribed drug to help keep me in remission, costs about $240,000 a year. Revlimid is classified as a hazardous drug and it can cause severe side-effects. I know because I have had them. If I had to choose between the two treatments, there’s no question I would choose the stem cell therapy even though it cost me money and the Revlimid doesn’t.
Long-term program: From ChatGPT (from the PROGRAM page):
• Start Low, Adjust as Needed: Begin with 2 cc or 4 cc per month and observe how the individual responds. Adjust based on health outcomes and goals.
• Regular Evaluations: Monitor health markers such as inflammation levels, energy, and overall quality of life to determine if the dosage is effective.
Conclusion
• 40 years old: 2 cc per month for maintenance; 4–6 cc for moderate to severe conditions.
• 50 years old: 2–4 cc per month for general health and moderate concerns; 6 cc for more advanced conditions.
• 60 years old: 4 cc per month for most individuals; 6 cc for aggressive therapy.
• 70 years old: 4 cc per month as a baseline; 6 cc for severe or progressive conditions.
• 80 years old: 4 cc per month minimum; 6 cc for significant therapeutic needs.
Consult a healthcare provider to determine the most appropriate dosage based on individual needs and goals.
Question:
Is it reasonable to reassess your long-term program periodically with regard to the dosage and frequency of the infusions?
ChatGPT:
After a year of monthly stem cell infusions, it is reasonable to reassess and adjust the dosage based on individual progress and health goals. Dosage adjustments can include:
• Reducing the dose per infusion (e.g., from 4 cc to 2 cc per month).
• Extending the time between infusions (e.g., shifting from monthly to bi-monthly treatments).
• Combining both (e.g., 2 cc every two months).
Reassessment is appropriate if:
• Health goals have been met (e.g., inflammation is under control or tissue repair is complete).
• Clinical markers and symptoms show stability or continued improvement.
However, reducing dosage should be monitored carefully to prevent relapse or regression. Long-term maintenance programs can involve lower doses or less frequent infusions to sustain benefits while minimizing costs and treatment intensity. Regular evaluations every 6–12 months ensure the therapy remains aligned with current health needs.
My experience:
The recommendations from ChatGPT reflect the impressions of myself and others who have participated in some form of a "Long-term Program". Individuals who have done this have experienced a much higher outcome success rate than those who choose to have one or two infusions.
Tax deduction possibilities:
Yes, there are circumstances where the cost of these treatments can be deducted for tax purposes. My tax advisor researched my particular circumstances and we are currently claiming these costs as a deduction. I cannot overemphasize the need for a person to consult with their own tax advisor before they consider this possibility. Here is something your tax advisor might consider in determining if your situation would qualify for a deduction:
Deductible medical expenses under Internal Revenue Code Sec. 213
According to Associate Chief Counsel George J. Blaine:
In Jacobs v. Commissioner (1974) and Stringham v. Commissioner (1949), courts have interpreted “cure, mitigation and treatment” as actions that address an existing or imminently probable disease, physical or mental defect or illness. The “imminent probability” standard enunciated by the courts requires a proximate and immediate link between the expenditure and a disease threatening the taxpayer.
Cord blood contains stem cells that doctors may use to treat disease. Thus, expenses for banking core blood to treat an existing or imminently probable disease may qualify as deductible medical expenses. However, banking cord blood as a precaution to treat a disease that might possibly develop in the future does not satisfy the existing legal standard that at a minimum a disease must be imminently probable.
____________________
STEM CELL THERAPY, INC.
LEGACY DONORS TO:
MD Anderson, Houston &
Keels & Wheels, Seabrook